Amgen Inc. (AMGN) has a consensus analyst rating of Buy, based on 38 analysts covering the stock. Of those, 22 recommend buying, 13 recommend holding, and 3 recommend selling.
The analyst consensus price target for AMGN is $347.73, representing a -0.9% downside from the current price of $350.95. Price targets range from a low of $185.00 to a high of $432.00.
